Healthcare - Biotechnology - NASDAQ - US
$ 1.78
2.3 %
$ 688 M
Market Cap
-0.56
P/E
INCOME STATEMENT
0
REVENUE
-100 M
OPERATING INCOME
-111 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Humacyte, Inc.
| Revenue | 0 |
| Cost Of Revenue | 76.6 M |
| Gross Profit | -76.6 M |
| Operating Expenses | 23.5 M |
| Operating Income | -100 M |
| Other Expenses | 10.7 M |
| Net Income | -111 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| REVENUE | |||||
| Revenue | 0 | 1.6 | 1.3 | 1.5 | 6.2 |
| GROSS PROFIT | |||||
| Cost Of Revenue | 76.5 | 8.3 | 49 K | 8.4 | 75.6 |
| Gross Profit | (76.5) | (6.7) | 1.2 | (6.9) | (69.4) |
| OPERATING INCOME | |||||
| Operating Expenses | 23.5 | 84.6 | 81.2 | 64.6 | 16.3 |
| Selling, General and Administrative Expenses | 20.4 | 22.9 | 21.1 | 12.0 | 16.3 |
| Research and Development Expenses | 76.5 | 63.3 | 61.3 | 54.1 | 75.6 |
| Operating Income | (100.0) | (84.6) | (81.2) | (64.6) | (85.7) |
| PRE-TAX INCOME | |||||
| Interest Income Expense | (6.6) | 6.2 | 4.3 | 2.2 | 2.3 |
| Total Other Income | (10.7) | 72.6 | 54.7 | (1.9) | 0.3 |
| Pre-Tax Income | (110.8) | (12.0) | (26.5) | (66.5) | (85.4) |
| NET INCOME | |||||
| Tax Provision | 0 | (76.2) | (64.0) | 2.2 | 0 |
| Net Income | (110.8) | 64.2 | 37.5 | (68.7) | (85.4) |
| EPS | 1.07 | 0.62 | 0.94 | 5.52 | 4.25 |